constipation glp 1 with GLP-1s: It's Common, and It's Manageable!: Women's Health Specialists, PLLC: OBGYNs GLP-1 Meds Slowed Your Digestion?

The trade-off is technique responsibility patients must learn proper subcutaneous injection and sterile handling to achieve clinic-equivalent safety

Most people try to lose weight through conventional methods such as diet and exercise

Diabetes constituted the majority of indications (n = 16,863, 58.2%), followed by weight control (n = 1,352, 4.7%) and non-diabetic blood glucose abnormalities (n = 556, 1.9%)

Additionally, while the most common side effect was mild to moderate gastrointestinal upset, there were fewer events per 100 patients across all of the cagrilintide treatment groups in comparison to the subjects receiving 3.0 mg of liraglutide [1]

Semaglutide 2.4 mg (Wegovy) and liraglutide 3.0 mg (Saxenda) are licensed for weight management in adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities